2017
Implementation of surgeon-initiated Oncotype DX ordering among patients with breast cancer to reduce chemotherapy wait times.
Losk K, Freedman R, Lin N, Golshan M, Lester S, Pochebit S, Natsuhara K, Camuso K, King T, Bunnell C. Implementation of surgeon-initiated Oncotype DX ordering among patients with breast cancer to reduce chemotherapy wait times. Journal Of Clinical Oncology 2017, 35: 166-166. DOI: 10.1200/jco.2017.35.8_suppl.166.Peer-Reviewed Original ResearchOncotype DX testingChemotherapy initiationMedical oncologistsBreast cancerConsecutive breast cancer patientsAdjuvant chemotherapy initiationBreast cancer patientsOncotype DX resultsPathology reviewClinical outcomesTumor characteristicsMedical oncologyOncotype DXCancer patientsPatient satisfactionSurgery dateSurgical oncologyPatientsTurnaround timeSurgeryIntervention implementationMean timeOncologistsSignificant reductionOrder date
2013
Reducing breast cancer chemotherapy treatment delays by improving the transition from surgical to medical oncology.
Losk K, Kadish S, Golshan M, Lin N, Hirshfield-Bartek J, Cutone L, Bunnell C, Weingart S. Reducing breast cancer chemotherapy treatment delays by improving the transition from surgical to medical oncology. Journal Of Clinical Oncology 2013, 31: 51-51. DOI: 10.1200/jco.2013.31.31_suppl.51.Peer-Reviewed Original ResearchInitiation of chemotherapyBreast cancer patientsMedical oncologyOncology followDefinitive surgeryCancer patientsConsecutive breast cancer patientsChemotherapy treatment delaysAdverse clinical outcomesBreast cancer careTransitions of careProcess of careAdjuvant chemotherapyTimely chemotherapyMedical oncologistsClinical outcomesTreatment delayBreast surgeryCancer careInitial consultationBreast surgeonsCare coordinationChemotherapySurgeryMultidisciplinary team